IADVL Academy Position Statement on Emerging Dermatoses in India: Monkeypox

Area of Science:

• Epidemiology
• Infectious Diseases
• Public Health

Background:

• The global landscape faces a new threat with the rapid emergence of monkeypox (human monkeypox), caused by the monkeypox virus, an orthopox virus.
• The outbreak has spread to over 80 countries, including India since July 2022, with a concerning increase in reported cases.
• This re-emerging viral disease presents with clinical manifestations that deviate from established knowledge.

Purpose of the Study:

• To alert and educate dermatologists on recognizing the evolving clinical features of monkeypox.
• To emphasize prompt response strategies for early containment of the monkeypox outbreak.
• To provide guidance in the absence of specific antiviral drugs and vaccines.

Main Methods:

• Clinical observation and recognition of atypical presentations.
• Emphasis on public health strategies for outbreak containment.
• Information dissemination to healthcare professionals.

Main Results:

• Monkeypox virus is spreading internationally with unusual clinical signs.
• India is experiencing a rise in monkeypox cases.
• The World Health Organization has declared the outbreak a Public Health Emergency of International Concern.

Conclusions:

• Early detection, isolation, and prevention of spread are the primary strategies for managing the monkeypox outbreak.
• Dermatologists play a key role in identifying and responding to the disease.
• The lack of specific antivirals and vaccines necessitates a focus on public health interventions.